Spatial organization of TLSs within the tumor microenvironment. Image shows TLSs containing T cells (green), B cells (pink), and follicular dendritic cells (cyan), surrounded by tumor cells (red) and ...

Orphan Drug Designation confers regulatory, financial and strategic advantagesEO2463 has shown potentially disease modifying activity in clinical ...

After Pam Bondi’s reported diagnosis, here’s what to know about thyroid cancer, treatment options, and survival rates.

The former attorney general was diagnosed shortly following her dismissal from the Trump Administration in early April.

News about former US Attorney General Pam Bondi’s cancer diagnosis emerged after her exit from the US Justice Department last ...

In the wake of Anthropic’s announcement of its latest artificial intelligence model, Mythos, on April 7, the company has stood by an unusual decision: refusing to release it to the public. Not since ...

Abstract: Histological analysis is the core of follicular thyroid carcinoma (FTC) classification. The histopathological criteria of capsular and vascular invasion define malignancy and aggressiveness ...

Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard ...

Follicular lymphoma, a common and usually slow-growing type of non-Hodgkin lymphoma (NHL), has long been deemed incurable: Though the disease responds well to initial treatment, oncologists tell ...

Thyroid nodules are common, occurring in more than half of the population. Fine-needle aspiration cytology (FNAC) combined with ultrasound is the first step in the analysis and diagnosis of thyroid ...

Melanotrichoblastoma (MTB) is an exceptionally rare benign adnexal tumor with follicular differentiation. Its clinical and dermoscopic resemblance to pigmented basal cell carcinoma (BCC) often leads ...

Reflecting on data presented at ASH 2025, Dr Kami Maddocks notes that several findings may change practice, including approval of epcoritamab combined with rituximab and lenalidomide (R2) for ...